← Leaderboards
Ryan Comfort Branski
New York University School Of Medicine
$7,514,357
Attributed
$7,747,419
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $863.8K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,747,419 · 7
By mechanism
R01$5,905,321 · 3
K24$829,985 · 1
R03$520,244 · 1
R21$466,125 · 1
F31$25,744 · 1
Top collaborators
- Michael J Garabedian2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Jill P Buyon$29,367,681
- Keng-Yen Huang$4,429,307
- Charlie Lenell Lunaris$106,596
- Michael J Garabedian$7,578,313
- Gary J Gartling$423,750
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightPhenotypeComplexFibroblastsLaboratoriesLesionInvestigationVocal CordInjuryFibrosisAcuteResponseStructureWound HealingSignal TransductionBaseRegenerativeCellsCicatrixHealingInjuredTissuesIn VitroAmerican
Grant awards (24)
Mechanisms of voice disorders associated with vocal fold atrophy$484,006
R01 · FY2025 · DC · contact PI
Midcareer Investigator Award in Patient-Oriented Research for Dr. Ryan Branski$165,997
K24 · FY2025 · DC · contact PI
Mechanisms of voice disorders associated with vocal fold atrophy$455,694
R01 · FY2024 · DC · contact PI
Molecular mechanisms underlying optimal glucocorticoid therapy for vocal fold disease$211,875
R21 · FY2024 · DC
Midcareer Investigator Award in Patient-Oriented Research for Dr. Ryan Branski$165,997
K24 · FY2024 · DC · contact PI
Molecular mechanisms underlying optimal glucocorticoid therapy for vocal fold disease$254,250
R21 · FY2023 · DC
Midcareer Investigator Award in Patient-Oriented Research for Dr. Ryan Branski$165,997
K24 · FY2023 · DC · contact PI
Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal folds$406,665
R01 · FY2022 · DC · contact PI
Midcareer Investigator Award in Patient-Oriented Research for Dr. Ryan Branski$165,997
K24 · FY2022 · DC · contact PI
Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal folds$630,711
R01 · FY2021 · DC · contact PI
Midcareer Investigator Award in Patient-Oriented Research for Dr. Ryan Branski$165,997
K24 · FY2021 · DC · contact PI
Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal folds$652,248
R01 · FY2020 · DC · contact PI
Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal folds$567,636
R01 · FY2019 · DC · contact PI
Optimal RNA-based therapeutics for vocal fold injury and fibrosis$481,125
R01 · FY2018 · DC · contact PI
Multiple mechanisms underlying GR-mediated therapies for fibroplasia of the vocal folds$382,639
R01 · FY2018 · DC · contact PI
Optimal RNA-based therapeutics for vocal fold injury and fibrosis$481,125
R01 · FY2017 · DC · contact PI
Optimal RNA-based therapeutics for vocal fold injury and fibrosis$483,125
R01 · FY2016 · DC · contact PI
Optimal RNA-based therapeutics for vocal fold injury and fibrosis$459,379
R01 · FY2015 · DC · contact PI
Optimal RNA-based therapeutics for vocal fold injury and fibrosis$420,968
R01 · FY2014 · DC · contact PI
Inflammation and Fibrosis of the Vocal Folds$163,592
R03 · FY2011 · DC · contact PI
Inflammation and Fibrosis of the Vocal Folds$153,729
R03 · FY2010 · DC · contact PI
Inflammation and Fibrosis of the Vocal Folds$14,378
R03 · FY2010 · DC · contact PI
Inflammation and Fibrosis of the Vocal Folds$188,545
R03 · FY2009 · DC · contact PI
The effects of strain on vocal fold fibroblasts$25,744
F31 · FY2004 · DC